Growth plate injury of the long bones in treated beta-thalassemia.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1546335.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 12 patients affected by thalassemia major who received an intensive transfusion regimen combined with continuous iron chelation therapy (desferrioxamine 50-80 mg/kg daily), radiologic abnormalities of the long bones were observed similar to those observed in rickets and scurvy. These abnormalities were associated with a growth retardation. The pathogenesis of these lesions is uncertain, but probably the toxic effect of desferrioxamine plays an important role in their development. A relative deficiency of vitamins D and/or C cannot be entirely excluded.
Medical subject headings
- Chelation Therapy
- Deferoxamine
- Growth Plate
- Thalassemia